Related Experiment Videos
[Expression of matrix metalloproteinase-2 in rat pulmonary fibrosis]
1Department of Pathology, School of Basic Medical Sciences, FuDan University, Shanghai 200032, China.
Objective:
To study the role of matrix metalloproteinase-2 (MMP(2)) in rat pulmonary fibrosis.
Methods:
(1) Dynamic changes of MMP(2) expression were observed in bleomycin-induced rat pulmonary fibrosis by use of immunohistochemical technique. (2) RT-PCR was carried out to show the dynamic changes of MMP(2) mRNA expression of isolated pulmonary fibroblasts (PFbs) during rat pulmonary fibrosis. (3) Northern blot analysis and immunocyto chemistry techniques were performed to detect the expression of MMP(2) mRNA and their relevant protein in cultured rat PFbs after treatment with transforming growth factor 1 (TGF beta(1)).
Results:
(1) On day 1-7th after receiving bleomycin, the infiltrated pulmonary macrophages and septa mesenchymal cells showed positive reaction with anti-MMP(2) and an increase in number. After 14 days and on 28 th of bleomycin treatment, the number of positive staining macrophages and mesenchymal cells were decreased respectively. (2) The gene expression of MMP(2) mRNA of PFbs were enhanced after bleomycin treatment from the Day 1 and decreased by Day 28. (3) The expression of MMP(2) mRNA and their relevant protein were enhanced in rat PFbs after TGF beta(1) treatment.
Conclusions:
Over expression of MMP(2) in pulmonary tissue may be an important factor in the initiation of pulmonary fibrogenesis.
Insights
Matrix metalloproteinase-2 (MMP-2) is upregulated in rat pulmonary fibrosis, suggesting its role in fibrogenesis. MMP-2 expression increases early in fibrosis and decreases over time.
Area of Science:
- Biochemistry
- Cell Biology
- Pulmonary Medicine
Context:
- Pulmonary fibrosis is a debilitating lung disease with limited treatment options.
- Matrix metalloproteinase-2 (MMP-2) is a key enzyme involved in extracellular matrix remodeling.
- Understanding MMP-2's role is crucial for developing targeted therapies.
Purpose:
- To investigate the expression and role of MMP-2 in a rat model of bleomycin-induced pulmonary fibrosis.
- To analyze the dynamic changes in MMP-2 mRNA and protein levels in lung tissue and isolated pulmonary fibroblasts (PFbs).
- To determine the effect of transforming growth factor-beta1 (TGF-β1) on MMP-2 expression in PFbs.
Summary:
- Bleomycin administration led to increased MMP-2 expression in pulmonary macrophages and mesenchymal cells, peaking within the first week and declining by day 28.
- MMP-2 mRNA levels in PFbs were elevated after bleomycin treatment, showing a similar dynamic pattern.
- TGF-β1 significantly enhanced both MMP-2 mRNA and protein expression in cultured rat PFbs.
Impact:
- The findings suggest that MMP-2 over-expression contributes to the initiation of pulmonary fibrogenesis.
- This study highlights MMP-2 as a potential therapeutic target for pulmonary fibrosis.
- Further research into MMP-2 modulation could lead to novel treatment strategies for lung fibrosis.